Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
buyout
3
×
life sciences
m&a
national blog main
national top stories
new york blog main
3
×
texas blog main
texas top stories
acquisition
allergan
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
celgene
detroit blog main
detroit top stories
drug prices
indiana blog main
indiana top stories
merger
nash
national
new york top stories
pricing
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
wisconsin blog main
wisconsin top stories
2019
3m
ace
What
ace
acelity
acquired
advanced
airport
alnylam’s
annual
antonio
apocalypse
approval
bandages
beds
bff
billion
bio
celgene
conference
days
deal
deals
devoted
disease
drug
easl
ending
fallout
form
gene
gone
home
ipo
j.p
jpm
kicked
liver
major
maker
notes
plan
post
Language
Current search:
buyout
×
photo
×
" new york blog main "
×
@xconomy.com
5 years ago
Acelity Sells to 3M in Deal Valued at $6.7 Billion, Ending IPO Plan
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More